BIOMERICA INC
Financial highlights
| Metric | FY 05/31/25 | FY 05/31/24 | FY 05/31/23 | FY 05/31/22 | FY 05/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.3M | $5.4M | $5.3M | $18.9M | $7.2M |
| Cost of revenue | $4.8M | $4.8M | $4.9M | $15.9M | $6.8M |
| Gross profit | $498,000 | $611,000 | $446,000 | $3.0M | $366,285 |
| Selling, general & administrative | $4.6M | $5.5M | $6.1M | $5.7M | $5.7M |
| Research and development | $1.0M | $1.5M | $1.6M | $1.8M | $2.2M |
| Operating expenses | $5.6M | $7.0M | $7.7M | $7.5M | $7.9M |
| Operating income | -$5.1M | -$6.4M | -$7.2M | -$4.5M | -$7.5M |
| Interest expense | — | — | — | — | $367 |
| Pretax income | -$5.0M | -$5.9M | -$7.1M | -$4.5M | -$7.4M |
| Income tax expense | $1,000 | $42,000 | $51,000 | $24,000 | $13,057 |
| Net income | -$5.0M | -$6.0M | -$7.1M | -$4.5M | -$7.4M |
| Balance Sheet | |||||
| Cash and equivalents | $2.4M | $4.2M | $9.7M | $5.9M | $4.2M |
| Current assets | $4.9M | $7.7M | $12.8M | $9.4M | $9.2M |
| Total assets | $5.9M | $9.3M | $14.5M | $11.4M | $11.8M |
| Current liabilities | $1.7M | $2.2M | $1.9M | $2.0M | $1.3M |
| Total liabilities | $1.8M | $2.7M | $2.7M | $3.0M | $2.6M |
| Stockholders' equity | $4.1M | $6.6M | $11.7M | $8.3M | $9.2M |
| Cash Flow Statement | |||||
| Cash from operations | -$3.8M | -$5.4M | -$5.5M | -$479,000 | -$5.3M |
| Depreciation and amortization | $87,000 | $81,000 | $84,000 | $339,000 | $105,000 |
| Stock-based compensation | $460,000 | $837,000 | $1.2M | $1.3M | $1.4M |
| Capital expenditure | — | $51,000 | $64,000 | $57,000 | $135,856 |
| Free cash flow | — | -$5.4M | -$5.5M | -$536,000 | -$5.4M |
| Impairments | — | — | $0 | $210,000 | $0 |
Shares outstanding 3.1M · Free float 63.9%
Annual filing data through FY ended May 31, 2025; float as of July 8, 2026.